Annual CFO
-$9.77 M
-$6.01 M-160.03%
31 December 2022
Summary:
Comera Life Sciences Holdings annual cash flow from operations is currently -$9.77 million, with the most recent change of -$6.01 million (-160.03%) on 31 December 2022. During the last 3 years, it has fallen by -$7.97 million (-441.64%). CMRA annual CFO is now -441.64% below its all-time high of -$1.80 million, reached on 31 December 2020.CMRA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$1.91 M
-$920.50 K-92.65%
30 September 2023
Summary:
Comera Life Sciences Holdings quarterly cash flow from operations is currently -$1.91 million, with the most recent change of -$920.50 thousand (-92.65%) on 30 September 2023. CMRA quarterly CFO is now -92.65% below its all-time high of -$993.50 thousand, reached on 30 June 2023.CMRA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$6.66 M
+$475.40 K+6.66%
30 September 2023
Summary:
Comera Life Sciences Holdings TTM cash flow from operations is currently -$6.66 million, with the most recent change of +$475.40 thousand (+6.66%) on 30 September 2023. CMRA TTM CFO is now -132.13% below its all-time high of -$2.87 million, reached on 31 March 2022.CMRA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMRA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -441.6% | - | - |
| 5 y5 years | - | - | - |
CMRA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -441.6% | at low | -92.7% | +33.3% | -132.1% | +31.8% |
| 5 y | 5 years | -441.6% | at low | -92.7% | +33.3% | -132.1% | +31.8% |
| alltime | all time | -441.6% | at low | -92.7% | +33.3% | -132.1% | +31.8% |
Comera Life Sciences Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$1.91 M(+92.7%) | -$6.66 M(-6.7%) |
| June 2023 | - | -$993.50 K(-47.9%) | -$7.14 M(-19.0%) |
| Mar 2023 | - | -$1.91 M(+3.1%) | -$8.81 M(-9.9%) |
| Dec 2022 | -$9.77 M | -$1.85 M(-22.7%) | -$9.77 M(+23.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$2.39 M(-10.3%) | -$7.92 M(+43.2%) |
| June 2022 | - | -$2.67 M(-7.1%) | -$5.53 M(+92.9%) |
| Mar 2022 | - | -$2.87 M | -$2.87 M |
| Dec 2021 | -$3.76 M(+108.3%) | - | - |
| Dec 2020 | -$1.80 M | - | - |
FAQ
- What is Comera Life Sciences Holdings annual cash flow from operations?
- What is the all time high annual CFO for Comera Life Sciences Holdings?
- What is Comera Life Sciences Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for Comera Life Sciences Holdings?
- What is Comera Life Sciences Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for Comera Life Sciences Holdings?
What is Comera Life Sciences Holdings annual cash flow from operations?
The current annual CFO of CMRA is -$9.77 M
What is the all time high annual CFO for Comera Life Sciences Holdings?
Comera Life Sciences Holdings all-time high annual cash flow from operations is -$1.80 M
What is Comera Life Sciences Holdings quarterly cash flow from operations?
The current quarterly CFO of CMRA is -$1.91 M
What is the all time high quarterly CFO for Comera Life Sciences Holdings?
Comera Life Sciences Holdings all-time high quarterly cash flow from operations is -$993.50 K
What is Comera Life Sciences Holdings TTM cash flow from operations?
The current TTM CFO of CMRA is -$6.66 M
What is the all time high TTM CFO for Comera Life Sciences Holdings?
Comera Life Sciences Holdings all-time high TTM cash flow from operations is -$2.87 M